HOME > About Us > Corporate Profile

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.

Corporate Profile

RIBOMIC Inc. is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Company Name RIBOMIC Inc.
Address 3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo 108-0071, Japan
Head Office and Administration Office:6F
Laboratories:2F, 3F, 4F
Date Established August 1, 2003
Date of IPO September 25, 2014 (Tokyo Stock Exchange Mothers Market, Company Code 4591)
Capital JPY 3,214Million
President and CEO Yoshikazu Nakamura
Employees 21(Ph.D.7 )
Subsidiary RIBOMIC USA Inc.
2120 University Ave Berkeley CA 94704 USA
CEO Yusuf Ali